These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 4035650
1. Substitution of antithrombin III in shock and DIC: a randomized study. Blauhut B, Kramar H, Vinazzer H, Bergmann H. Thromb Res; 1985 Jul 01; 39(1):81-9. PubMed ID: 4035650 [Abstract] [Full Text] [Related]
5. [Antithrombin III substitution in patients in shock]. Vinazzer H, Blauhut B, Bergmann H. Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Jul 01; 111(6):806-16. PubMed ID: 6083957 [Abstract] [Full Text] [Related]
6. Substitution therapy with an antithrombin III concentrate in shock and DIC. Blauhut B, Necek S, Vinazzer H, Bergmann H. Thromb Res; 1982 Aug 01; 27(3):271-8. PubMed ID: 7135359 [Abstract] [Full Text] [Related]
7. [Therapy with antithrombin III concentrate]. Vinazzer H. Haematologica; 1990 Aug 01; 75 Suppl 2():14-20. PubMed ID: 2201604 [No Abstract] [Full Text] [Related]
9. [Substitution of antithrombin III in shock and consumption coagulopathy]. Blauhut B, Bergmann H, Vinazzer H. Wien Klin Wochenschr; 1984 Dec 21; 96(24):879-81. PubMed ID: 6528617 [Abstract] [Full Text] [Related]
10. Treatment of DIC with antithrombin III concentrates. Sakata Y, Yoshida N, Matsuda M, Aoki N. Bibl Haematol; 1983 Dec 21; (49):307-16. PubMed ID: 6667252 [Abstract] [Full Text] [Related]
11. Clinical use of antithrombin III concentrates. Vinazzer H. Vox Sang; 1987 Dec 21; 53(4):193-8. PubMed ID: 3326267 [Abstract] [Full Text] [Related]
12. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children. Hanada T, Abe T, Takita H. Am J Pediatr Hematol Oncol; 1985 Dec 21; 7(1):3-8. PubMed ID: 4037242 [Abstract] [Full Text] [Related]
13. Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. Giebler R, Schmidt U, Koch S, Peters J, Scherer R. Crit Care Med; 1999 Mar 21; 27(3):597-604. PubMed ID: 10199542 [Abstract] [Full Text] [Related]
15. [Therapy with antithrombin III in burned children--pilot study]. Del Principe D, Pietrantoni R, Menichelli A, Siviero MC, Luzi F, Colucci C, Orsini D. Haematologica; 1990 Mar 21; 75 Suppl 2():33-40. PubMed ID: 2387549 [No Abstract] [Full Text] [Related]
16. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)]. Takahashi K. Nihon Ketsueki Gakkai Zasshi; 1980 Oct 21; 43(5):889-97. PubMed ID: 6940410 [No Abstract] [Full Text] [Related]
17. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Vinazzer H. Semin Thromb Hemost; 1989 Jul 21; 15(3):347-52. PubMed ID: 2688106 [No Abstract] [Full Text] [Related]
18. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)]. Bergmann H, Blauhut B, Necek S, Kramar H, Vinazzer H. Anaesthesist; 1980 Nov 21; 29(11):623-6. PubMed ID: 7457802 [Abstract] [Full Text] [Related]
19. Endotoxin-induced intravascular coagulation (DIC) and its therapy. Prager RL, Dunn EL, Kirsh MM, Penner JA. Adv Shock Res; 1979 Nov 21; 2():277-87. PubMed ID: 400581 [Abstract] [Full Text] [Related]